PET Scan Prior Authorization Denied: What to Do Next
Why Insurers Deny PET Scan Prior Authorization
Key Takeaway: PET denials fall into five categories: medical necessity, NCCN criteria not met, missing prior auth, conservative imaging not attempted, and experimental classification. Your EOB denial code determines which rebuttal strategy to use.
PET scans cost insurers $3,000–$6,000 per study — making them one of the most scrutinized imaging authorizations. In my experience handling oncology imaging appeals, denials rarely question whether PET works. They question whether your specific clinical scenario meets the plan's criteria for when PET is appropriate.
The five most common denial reasons:
- Medical necessity not established: Insurer argues CT or MRI already provides sufficient staging information.
- NCCN criteria not met: Your cancer type or stage does not match the plan's interpretation of NCCN guidelines for PET.
- Prior authorization not obtained: The scan was scheduled before auth was approved — a procedural denial, not a clinical one.
- Conservative imaging not attempted: Plan requires CT first; PET requested as initial staging without documented CT limitations.
- Experimental or investigational: PET for certain cancer types or restaging intervals the plan considers outside standard of care.
Step-by-Step: How to Appeal a Denied PET Scan Authorization
Key Takeaway: File your internal appeal before the deadline, attach complete oncology documentation, and request expedited review if treatment decisions depend on staging results. Keep copies of everything.
- Confirm your appeal deadline. ERISA plans: 180 days. ACA marketplace: 60 days. For cancer staging, request expedited processing immediately.
- Request your complete claim file. Under ERISA §503, obtain all documents used in the denial — including the plan's internal PET criteria.
- Get an oncology letter of medical necessity. Must cite NCCN guidelines for your specific cancer type and explain why PET changes treatment decisions.
- Attach pathology and prior imaging. Biopsy results, CT reports showing limitations, and tumor markers strengthen staging appeals.
- Write and submit your formal appeal letter. Address the specific denial code, cite appeal rights, and list every attachment.
- Submit through the correct radiology portal. Availity, eviCore, or RadMD — confirm receipt.
- Follow up at 7 and 14 days. For expedited appeals, follow up at 48 hours. Document every call.
- If denied again, request external review. Independent reviewers evaluate NCCN compliance — not just plan cost controls.
Weak vs. Strong PET Appeal Language (Before & After)
Key Takeaway: Oncology medical directors approve PET appeals when the letter explains how staging results will change treatment — not when it simply states the doctor ordered a scan.
| ❌ Weak Statement | ✅ Strong Statement |
|---|---|
| “My oncologist ordered a PET scan for cancer staging. Please approve.” | “FDG-PET/CT staging per NCCN Guidelines for Non-Small Cell Lung Cancer v4.2026, Category 2A. Biopsy-confirmed adenocarcinoma (pathology 07/12/2026). PET required to distinguish Stage IIIA from IIIB — directly determines surgical candidacy vs. chemoradiation.” |
| “CT scan was not good enough. We need a better scan.” | “Contrast CT chest/abdomen (07/08/2026) shows 3.2 cm RUL mass with indeterminate mediastinal lymphadenopathy (short axis 9 mm). PET required per NCCN to characterize nodal FDG avidity and exclude distant metastases before treatment planning.” |
| “This is medically necessary. FDA approves PET scans for cancer.” | “I formally request expedited internal appeal under ACA §2719. Denial code IMG-NMN-04. Attached: oncology letter of medical necessity, pathology report, CT report, and NCCN guideline excerpt for NSCLC staging workup.” |
Need a PET Scan Appeal Letter Drafted?
AppealFlow's free Imaging Appeal Generator creates a medical necessity letter citing NCCN criteria and oncology staging rationale — ready in under 60 seconds.
Building Your Oncology Medical Necessity Packet
Key Takeaway: A complete PET appeal packet has six components: oncology letter, pathology results, prior imaging reports, NCCN guideline citation, treatment plan impact statement, and the denial letter. Missing pathology is the most common reason staging appeals fail.
Your oncologist's letter of medical necessity should address:
- Cancer type, stage (if known), and ICD-10 diagnosis code
- Specific NCCN guideline recommendation for PET at this clinical point
- How PET results will change treatment decisions (surgery vs. chemo vs. radiation)
- Prior imaging results and their limitations
- Biopsy or pathology confirmation with date
- Prescriber credentials, NPI, and signature
For restaging PET scans (not initial staging), the letter must explain why restaging is clinically indicated — disease progression on imaging, new symptoms, or evaluation after treatment completion per NCCN follow-up guidelines.
Submitting Through Radiology Portals (Availity, eviCore, RadMD)
Key Takeaway: PET prior auth appeals route through radiology benefit managers — not standard medical claims portals. Submitting to the wrong system delays appeals by weeks.
| Platform | Used By | Appeal Submission |
|---|---|---|
| Availity | Aetna, many BCBS plans, Humana | Provider or member portal → Authorizations → Appeal with clinical attachments |
| eviCore | UnitedHealthcare, Anthem, some regional plans | eviCore healthcare portal → Imaging → Prior Auth Appeal; fax backup available |
| RadMD | Multiple national carriers for radiology benefits | RadMD.com provider portal → Appeal submission with NCCN documentation |
| Carelon (formerly AIM) | Anthem, some BCBS affiliates | Carelon portal → Advanced imaging appeals with oncology letter attached |
Your denial letter lists the correct portal and fax number. If your oncologist's office initiated the original prior auth, ask them to file the appeal through the same system. Follow up yourself to confirm submission before your deadline.
Citing NCCN Guidelines in Your PET Appeal
Key Takeaway: Generic references to “NCCN guidelines” are insufficient. Cite the specific cancer type, guideline version, recommendation category, and clinical scenario that supports PET at this point in workup.
NCCN guidelines are the gold standard insurers use to evaluate oncology imaging appeals. Your prescriber should cite the exact recommendation — for example:
- NSCLC: NCCN Guidelines recommend FDG-PET/CT for Stage I–III staging when curative treatment is planned
- Hodgkin lymphoma: PET/CT at initial staging and interim restaging per NCCN Category 1 recommendation
- Colorectal cancer: PET generally not recommended for routine staging — but indicated when CT suggests potentially resectable metastatic disease
- Melanoma: PET/CT for Stage III–IV staging when standard imaging is equivocal
Include a printed excerpt from the relevant NCCN guideline page as an attachment. Medical directors reviewing appeals respond to specific guideline citations — not general statements that PET is standard for cancer.
Realistic Timelines and Success Rates for PET Appeals
Key Takeaway: Expedited oncology appeals should be decided within 72 hours. Complete NCCN-documented appeals succeed roughly 50–65% on first internal submission. Incomplete appeals succeed less than 15%.
For cancer staging, always request expedited review. Your oncologist must certify that delay would seriously jeopardize your health or ability to regain maximum function. Standard 30-day timelines are unacceptable when treatment planning is on hold.
Common myth: Paying out-of-pocket for a PET scan and appealing for retroactive authorization rarely works for oncology imaging. Most plans prohibit retroactive approval. File the appeal before the scan, or ask your facility about self-pay rates and financial assistance while waiting.
Five Mistakes That Kill PET Scan Appeals
Key Takeaway: PET appeals fail when the oncology letter does not explain treatment impact. A scan order alone is not medical necessity — changed treatment decisions are.
- Generic oncology letters without NCCN citations. Demand a detailed letter from your oncologist addressing the specific denial code.
- Missing pathology or biopsy results. Staging PET appeals without tissue confirmation are weak.
- Not requesting expedited review for cancer staging. Standard 30-day timelines delay treatment.
- Submitting to the wrong portal. Medical claims appeals do not reach radiology benefit managers.
- Not requesting external review after internal denial. Independent reviewers often overturn well-documented oncology cases.
Frequently Asked Questions
Answers to the most common PET scan prior authorization appeal questions.
Generate Your Free PET Scan Appeal Letter
AppealFlow.net drafts a formal medical necessity appeal citing NCCN guidelines, oncology staging rationale, and insurer appeal rights — edit it live, then download as PDF or Word. No account required.
- 100% Free
- No Signup
- PDF & Word Export
Disclaimer: This article is for educational purposes only and does not constitute medical or legal advice. AppealFlow.net is not a healthcare provider or law firm. Success rates cited are estimates based on industry advocacy data and vary by plan. Always review appeal letters with your oncologist before submission. For medical emergencies, call 911. See our full disclaimer.